Clinical Trials Research
Findings from Harvard University, Dana-Farber Cancer Institute broaden understanding of clinical trials research
Published in Gene Therapy Weekly, December 23rd, 2010
2010 DEC 23 -- Data detailed in 'Rectal dose-volume histogram parameters are associated with long-term patient-reported gastrointestinal quality of life after conventional and high-dose radiation for prostate cancer: a subgroup analysis of a randomized trial' have been presented. "We examined whether rectal dose-volume histogram (DVH) parameters were associated with long-term patient-reported gastrointestinal (GI) quality of life (QOL) after conventional (70.2 GyE) or high-dose (79.2 GyE) radiation for prostate cancer. Of 64 men with localized prostate cancer alive with a minimum 7-year follow-up after treatment as part of a randomized trial with either 70.2 GyE or 79.2 GyE of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2010-12-23)
More Articles from Gene Therapy Weekly
- Gene Therapy
Data on gene therapy published by researchers at Catholic University, Institute of Anatomy and Cell Biology - Gene Therapy
Early safety results promising for Phase I/II trial of gene therapy treatment of hemophilia B - Gene Therapy
Findings from Thomas Jefferson University broaden understanding of gene therapy - Gene Therapy
New NIH grant helps MU scientist get to the heart of muscular dystrophy - Antisense Technology
New research on antisense technology from University of Paris summarized - Small Interference RNAs (siRNAs)
New small interference RNAs (sirnas) research has been reported by scientists at Russian Academy of Science - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
